|
MechanismAP4M1 stimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with CureSPG50
0 Patents (Medical) associated with CureSPG50
100 Deals associated with CureSPG50
100 Translational Medicine associated with CureSPG50